Regulation of nicotinic acetylcholine receptor assembly

Annals of the New York Academy of Sciences

Volumn 998, Issue , 2003, Pages 66-80

  Wanamaker, Christian P ^a   Christianson, John C ^a,b   Green, William N ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Assembly; Degradation; Endoplasmic reticulum (ER); Nicotinic acetylcholine receptor (AChR); Ubiquitin proteasome system (UPS)

Indexed keywords

ACETYLCHOLINE RECEPTOR ALPHA; ACETYLCHOLINE RECEPTOR BETA; ACETYLCHOLINE RECEPTOR DELTA; ACETYLCHOLINE RECEPTOR GAMMA; CHAPERONE; CHOLERA TOXIN; CYCLIC AMP; FORSKOLIN; GAP JUNCTION PROTEIN; ION CHANNEL; MEMBRANE PROTEIN; NICOTINIC RECEPTOR; PROTEASOME; PROTEASOME INHIBITOR; RECEPTOR SUBUNIT; RHODOPSIN; TETRAMER; THEOPHYLLINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BINDING SITE; CELL SURFACE; COMPARATIVE STUDY; CONFERENCE PAPER; ENDOPLASMIC RETICULUM; MUSCLE SPINDLE; NONHUMAN; OLIGOMERIZATION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

EID: 0141839053     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1254.009     Document Type: Conference Paper

References (94)

1. PATRICK, J. & J. LINDSTROM. 1973. Autoimmune response to acetylcholine receptor. Science 180: 871-872.
2. SINE, S. et al. 1995. Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 15: 229-239.
3. QUIRAM, P.A. et al. 1999. Mutation causing congenital myasthenia reveals acetylcholine receptor beta/delta subunit interaction essential for assembly. J. Clin. Invest. 104: 1403-1410.
4. CHENG, S.H. et al. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834.
5. GREEN, W.N., A.F. ROSS & T. CLAUDIO. 199. Acetylcholine receptor assembly is stimulated by phosphorylation of its γ subunit. Neuron 7: 659-666.
6. ROTHHUT, B. et al. 1996. Post-translational regulation of neuronal acetylcholine receptors stably expressed in a mouse fibroblast cell line. J. Neurobiol. 29: 115-125.
7. ELLGAARD, L., M. MOLINARI & A. HELENIUS. 1999. Setting the standards: quality control in the secretory pathway. Science 286: 1882-1888.
8. KOPITO, R.R. 1997. ER quality control: the cytoplasmic connection. Cell 88: 427-430.
9. UNWIN, N. 1993. Neurotransmitter action: opening of ligand-gated ion channels. Cell (Suppl.) 72: 31-41.
10. BREJC, K. et al. 2001. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411: 269-276.
11. SINE, S.M. 2002. The nicotinic receptor ligand binding domain. J. Neurobiol. 53: 431-446.
12. KARLIN, A. & M.H. AKABAS. 1995. Towards a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15: 1231-1244.
13. KLAUSNER, R.D., J. LIPPINCOTT-SCHWARTZ & J.S. BONIFACINO. 1990. The T cell antigen receptor: insights into organelle biology. Annu. Rev. Cell Biol. 6: 403-431.
14. OLSON, T.S., M.J. BAMBERGER & M.D. LANE. 1988. Post-translational changes in tertiary and quaternary structure of the insulin proreceptor. J. Biol. Chem. 263: 7342-7351.
15. MERLIE, J.P. & J. LINDSTROM. 1983. Assembly in vivo of mouse muscle acetylcholine receptor: identification of an alpha subunit species that may be an assembly intermediate. Cell 34: 747-757.
16. COPELANO, C.S. et al. 1986. Assembly of influenza hemagglutinin trimers and its role in intracellular transport. J. Cell Biol. 103: 1179-1191.
17. GETHING, M-J., K. MCKANNON & J. SAMBROOK. 1986. Expression of wildtype and mutant forms of influenza hemagglutinin: the role of folding in transport. Cell 46: 939-950.
18. BLOUNT, P., M.M. SMITH & J.P. MERLIE. 1990. Assembly intermediates of the mouse muscle nicotinic acetylcholine receptor in stably transfected fibroblasts. J. Cell Biol. 111: 2601-2611.
19. SAEDI, M.S., W.G. CONROY & J. LINDSTROM. 1991. Assembly of Torpedo acetylcholine receptors in Xenopus oocytes. J. Cell Biol. 112: 1007-1015.
20. GU, Y. et al. 1991. Assembly of mammalian muscle acetylcholine receptors in transfected COS cells. J. Cell Biol. 114: 799-807.
21. KREIENKAMP, H.J. et al. 1995. Intersubunit contacts governing assembly of the mammalian nicotinic acetylcholine receptor. Neuron 14: 635-644.
22. GREEN, W.N. & T. CLAUDIO. 1993. Acetylcholine receptor assembly: subunit folding and oligomerization occur sequentially. Cell 74: 57-69.
23. GREEN, W.N. & C.P. WANAMAKER. 1997. The role of the cystine loop in acetylcholine receptor assembly. J. Biol. Chem. 272: 20945-20953.
24. GREEN, W.N. & C.P. WANAMAKER. 1998. Formation of the nicotinic acetylcholine receptor binding sites. J. Neurosci. 18: 5555-5564.
25. EERTMOED, A.L. & W.N. GREEN. 1999. Nicotinic receptor assembly requires multiple regions throughout the gamma subunit. J. Neurosci. 19: 6298-6308.
26. MITRA, M., C.P. WANAMAKER & W.N. GREEN. 2001. Rearrangement of nicotinic receptor alpha subunits during formation of the ligand binding sites. J. Neurosci. 21: 3000-3008.
27. NICKE, A. et al. 1999. Blue native PAGE as a useful method for the analysis of the assembly of distinct combinations of nicotinic acetylcholine receptor subunits. J. Recept. Signal. Transduct. Res. 19: 493-507.
28. DEAL, K.K., D.M. LOVINGER & M.M. TAMKUN. 1994. The brain Kv1.1 potassium channel: in vitro and in vivo studies on subunit assembly and posttranslational processing. J. Neurosci. 14: 1666-1676.
29. + channel surface expression through effects early in biosynthesis. Neuron 16: 843-852.
30. GU, Y. et al. 1991. Identification of two amino acid residues in the ε subunit that promote mammalian muscle acetylcholine recptor asssembly in COS cells. Neuron 6: 879-887.
31. YU, X-M. & Z.W. HALL. 1991. Extracellular domains mediating ε subunit interactions of muscle acetylcholine receptor. Nature 352: 64-67.
32. SUMIKAWA, K. & T. NISHIZAKI. 1994. The amino acid residues 1-128 in the alpha subunit of the nicotinic acetylcholine receptor contain assembly signals. Brain Res. Mol. Brain Res. 25: 257-264.
33. LI, M., Y.N. JAN & L.Y. JAN. 1992. Specification of subunit assembly by the hydrophilic amino-terminal domain of the Shaker potassium channel. Science 257: 1225-1230.
34. + channel assembly. Neuron 11: 67-76.
35. ROSENBERG, R.L. & J.E. EAST. 1992. Cell-free expression of functional Shaker potassium channels. Nature 360: 166-169.
36. SMITH, M.M., J. LINDSTROM & J.P. MERLIE. 1987. Formation of the α-bungarotoxin binding site and assembly of the acetylcholine receptor subunits occur in the endoplasmic reticulum. J. Biol. Chem. 262: 4367-4376.
37. GU, Y. et al. 1989. Acetylcholine receptors in a C2 muscle cell variant is retained in the endoplasmic reticulum. J. Cell Biol. 109: 729-738.
38. ROSS, A.F. et al. 1991. Efficiency of acetylcholine receptor subunit assembly and its regulation by cAMP. J. Cell Biol. 113: 623-636.
39. GELMAN, M.S. et al. 1995. Role of the endoplasmic reticulum chaperone calnexin in subunit folding and assembly of nicotinic acetylcholine receptors. J. Biol. Chem. 270: 15085-15092.
40. COOPER, S.T. & N.S. MILLAR. 1997. Host cell-specific folding and assembly of the neuronal nicotinic acetylcholine receptor alpha7 subunit. J. Neurochem. 68: 2140-2151.
41. RANGWALA, F. et al. 1997. Neuronal alpha-bungarotoxin receptors differ structurally from other nicotinic acetylcholine receptors. J. Neurosci. 17: 8201-8212.
42. COOPER, S.T. & N.S. MILLAR. 1998. Host cell-specific folding of the neuronal nicotinic receptor alpha8 subunit. J. Neurochem. 70: 2585-2593.
43. GETHING, M.J. 1999. Role and regulation of the ER chaperone BiP. Semin. Cell Dev. Biol. 10: 465-472.
44. ELLGAARD, L. & A. HELENIUS. 2001. ER quality control: towards an understanding at the molecular level. Curr. Opin. Cell Biol. 13: 431-437.
45. HIGH, S. et al. 2000. Glycoprotein folding in the endoplasmic reticulum: a tale of three chaperones? FEBS Lett. 476: 38-41.
46. BRODSKY, J.L. & A.A. MCCRACKEN. 1999. ER protein quality control and proteasome-mediated protein degradation. Semin. Cell Dev. Biol. 10: 507-513.
47. KELLER, S.H., J. LINDSTROM & P. TAYLOR. 1996. Involvement of the chaperone protein calnexin and the acetylcholine receptor beta-subunit in the assembly and cell surface expression of the receptor. J. Biol. Chem. 271: 22871-22877.
48. KELLER, S.H., J. LINDSTROM & P. TAYLOR. 1998. Inhibition of glucose trimming with castanospermine reduces calnexin association and promotes proteasome degradation of the alpha-subunit of the nicotinic acetylcholine receptor. J. Biol. Chem. 273: 17064-17072.
49. BLOUNT, P. & J.P. MERLIE. 1991. BIP associates with newly synthesized subunits of the mouse muscle nicotinic receptor. J. Cell Biol. 113: 1125-1132.
50. PAULSON, H.L. et al. 1991. Analysis of early events in acetycholine receptor assembly. J. Cell Biol. 113: 1371-1384.
51. FORSAYETH, J.R., Y. GU & Z.W. HALL. 1992. BiP forms stable complexes with unassembled subunits of the acetylcholine receptor in transfected COS cells and in C2 muscle cells. J. Cell Biol. 117: 841-847.
52. CHANG, W., M.S. GELMAN & J.M. PRIVES. 1997. Calnexin-dependent enhancement of nicotinic acetylcholine receptor assembly and surface expression. J. Biol. Chem. 272: 28925-28932.
53. MOLINARI, M. & A. HELENIUS. 2000. Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 288: 331-333.
54. SRIVASTAVA, S.P., J.A. FUCHS & J.L. HOLTZMAN. 1993. The reported cDNA sequence for phospholipase C alpha encodes protein disulfide isomerase, isozyme Q-2, and not phospholipase-C. Biochem. Biophys. Res. Commun. 193: 971-978.
55. BOURDI, M. et al. 1995. cDNA cloning and baculovirus expression of the human liver endoplasmic reticulum P58: characterization as a protein disulfide isomerase isoform, but not as a protease or a carnitine acyltransferase. Arch. Biochem. Biophys. 323: 397-403.
56. HIRANO, N. et al. 1995. Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase: identification of its secretory form and inducible expression by the oncogenic transformation. Eur. J. Biochem. 234: 336-342.
57. MOLINARI, M. & A. HELENIUS. 1999. Glycoproteins form mixed disulphides with oxidoreductases during folding in living cells. Nature 402: 90-93.
58. PLEMPER, R.K. & D.H. WOLF. 1999. Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem. Sci. 24: 266-270.
59. GLICKMAN, M.H. & A. CIECHANOVER. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82: 373-428.
60. RABINOVICH, E. 2001. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Nature 414: 652-656.
61. YE, Y. 2001. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Cell 107: 667-677.
62. JAROSCH, E. et al. 2002. Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat. Cell Biol. 4: 134-139.
63. XIONG, X., E. CHONG & W.R. SKACH. 1999. Evidence that endoplasmic reticulum (ER)-associated degradation of cystic fibrosis transmembrane conductance regulator is linked to retrograde translocation from the ER membrane. J. Biol. Chem. 274: 2616-2624.
64. PLEMPER, R.K. et al. 1998. Endoplasmic reticulum degradation of a mutated ATP-binding cassette transporter Pdr5 proceeds in a concerted action of Sec61 and the proteasome. J. Biol. Chem. 273: 32848-32856.
65. CLAUDIO, T. et al. 1989. Fibroblasts transfected with Torpedo acetylcholine receptor beta, gamma, and delta subunit cDNA's express functional receptors when infected with a retroviral alpha recombinant. J. Cell Biol. 108: 2277-2290.
66. BLOUNT, P. & J.P. MERLIE. 1988. Native folding of an acetylcholine receptor alpha subunit expressed in the absence of other receptor subunits. J. Biol. Chem. 263: 1072-1080.
67. SUMIKAWA, K. & R. MILEDI. 1989. Assembly and N-glycosylation of all ACh receptor subunits are required for their efficient insertion into plasma membranes. Mol. Brain Res. 5: 183-192.
68. HYMAN, C. & S.C. FROEHNER. 1983. Degradation of acetylcholine receptors in muscle cells: effect of leupeptin on turnover rate, intracellular pool sizes, and receptor properties. J. Cell Biol. 96: 1316-1324.
69. YANG, M. et al. 1998. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J. Exp. Med. 187: 835-846.
70. YU, H. et al. 1997. Cytosolic degradation of T-cell receptor alpha chains by the proteasome. J. Biol. Chem. 272: 20800-20804.
71. TIWARI, S. 2001. Endoplasmic reticulum (ER)-associated degradation of T cell receptor subunits: involvement of ER-associated ubiquitin-conjugating enzymes (E2s). J. Biol. Chem. 276: 16193-16200.
72. + channel (ENaC) by ubiquitination. EMBO J. 16: 6325-6336.
73. MALIK, B. et al. 2001. Enac degradation in A6 cells by the ubiquitin-proteosome proteolytic pathway. J. Biol. Chem. 276: 12903-12910.
74. MUSIL, L.S. et al. 2000. Regulation of connexin degradation as a mechanism to increase gap junction assembly and function. J. Biol. Chem. 275: 25207-25215.
75. JENSEN, T.J. et al. 1995. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83: 129-135.
76. ILLING, M.E. et al. 2002. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J. Biol. Chem. 277: 34150-34160.
77. WARD, C.L., S. OMURA & R.R. KOPITO. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83: 121-127.
78. LEE, D.H. & A.L. GOLDBERG. 1998. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8: 397-403.
79. ELLIOTT, P.J. & J.S. ROSS. 2001. The proteasome: a new target for novel drug therapies. Am. J. Clin. Pathol. 116: 637-646.
80. MOSS, A. et al. 2002. A role of the ubiquitin-proteasome system in neuropathic pain. J. Neurosci. 22: 1363-1372.
81. CIECHANOVER, A. & A.L. SCHWARTZ. 1998. The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death [comment]. Proc. Natl. Acad. Sci. USA 95: 2727-2730.
82. HILT, W. & D.H. WOLF. 1996. Proteasomes: destruction as a programme. Trends Biochem. Sci. 21: 96-102.
83. HALLIWELL, B. 2002. Hypothesis: proteasomal dysfunction - a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann. N.Y. Acad. Sci. 962: 182-194.
84. IMAI, Y. et al. 2002. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell 10: 55-67.
85. SHAN, H. et al. 2001. HRD gene dependence of endoplasmic reticulum-associated degradation. J. Biol. Chem. 276: 8681-8694.
86. YOSHIDA, Y. et al. 2002. E3 ubiquitin ligase that recognizes sugar chains. Nature 418: 438-442.
87. SWANSON, R., M. LOCHER & M. HOCHSTRASSER. 2001. A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation. Genes Dev. 15: 2660-2674.
88. FANG, S. et al. 2001. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 98: 14422-14427.
89. ZERANGUE, N. et al. 1999. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22: 537-548.
90. KELLER, S.H. et al. 2001. Adjacent basic amino acid residues recognized by the COP I complex and ubiquitination govern endoplasmic reticulum to cell surface trafficking of the nicotinic acetylcholine receptor alpha-subunit. J. Biol. Chem. 276: 18384-18391.
91. MARCHAND, S. et al. 2002. Rapsyn escorts the nicotinic acetylcholine receptor along the exocytic pathway via association with lipid rafts. J. Neurosci. 22: 8891-8901.
92. OHNO, K. et al. 2002. Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. Am. J. Hum. Genet. 70: 875-885.
93. GREEN, W.N., A.F. ROSS & T. CLAUDIO. 1991. cAMP stimulation of acetylcholine receptor expression is mediated through posttranslational mechanisms. Proc. Natl. Acad. Sci. USA 88: 854-858.
94. BERCOVICH, B. et al. 1999. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. J. Biol. Chem. 274: 14823-14830.